Clinical Trials List
Protocol NumberCYTB323K12201
Active
2024-01-02 - 2030-01-02
Phase II
Recruiting1
ICD-10M34.0
Progressive systemic sclerosis
ICD-10M34.1
CR(E)ST syndrome
ICD-10M34.2
Systemic sclerosis induced by drug and chemical
ICD-10M34.89
Other systemic sclerosis
ICD-10M34.9
Systemic sclerosis, unspecified
ICD-9710.1
Systemic sclerosis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 高宗楙 風濕免疫科
- 陳彥如 風濕免疫科
- CHIH-HUNG LAI Division of Cardiovascular Diseases
- 洪維廷 無
- Yi-Ming Chen 風濕免疫科
- 謝佳偉 風濕免疫科
- 許鶴忀 風濕免疫科
- Huey-En Tzeng Division of General Internal Medicine
- 賴國隆 風濕免疫科
- Kuan-Der Lee Division of General Internal Medicine
- HSIN-HUA CHEN 風濕免疫科
- 廖育婉 風濕免疫科
- 顏在弘 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
96 participants
